# Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy.

> PubMed lists PMID 39126516 in Acta diabetologica as Journal Article, with publication-date metadata of 2024-08-10 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39126516-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-11-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39126516-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39126516-dulaglutide-v1.json
- Content SHA-256: `c8f95f694f143eae77614d5796644205af291488f7e02195e875183180517f0a`

## Claims and source pins

### Headline

Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy. ([`pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601`](#source-pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601))

### Summary

PubMed lists PMID 39126516 in Acta diabetologica as Journal Article, with publication-date metadata of 2024-08-10 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601`](#source-pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601))

### Paragraph 1

PubMed lists PMID 39126516 in Acta diabetologica as Journal Article, with publication-date metadata of 2024-08-10 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601`](#source-pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601`](#source-pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601))

## Sources

<a id="source-pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601"></a>
- **Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy. · retained source version 1:2024-11-05:current:ac3e203c860189e07048cca6ff4027b5b2ccc8713e68d945bd17c01c8584ba4b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39126516/) (`pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39126516-dulaglutide-v1.json SHA-256: c8f95f694f143eae77614d5796644205af291488f7e02195e875183180517f0a.